Free Cash Flow to Equity (FCFE)
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
Item | Description | The company |
---|---|---|
FCFE | Free cash flow to equity is the cash flow available to Express Scripts Holding Co. equity holders after all operating expenses, interest, and principal payments have been paid and necessary investments in working and fixed capital have been made. | Express Scripts Holding Co. FCFE decreased from 2015 to 2016 but then slightly increased from 2016 to 2017. |
Price to FCFE Ratio, Current
No. shares of common stock outstanding | 563,860,000 |
Selected Financial Data (US$) | |
Free cash flow to equity (FCFE) (in thousands) | 5,552,600) |
FCFE per share | 9.85 |
Current share price (P) | 96.97 |
Valuation Ratio | |
P/FCFE | 9.85 |
Benchmarks | |
P/FCFE, Competitors1 | |
Abbott Laboratories | 77.82 |
Cigna Group | 9.03 |
CVS Health Corp. | 3.90 |
Elevance Health Inc. | 12.47 |
Humana Inc. | 9.68 |
Intuitive Surgical Inc. | 257.45 |
Medtronic PLC | 17.20 |
UnitedHealth Group Inc. | 18.44 |
Based on: 10-K (reporting date: 2017-12-31).
1 Click competitor name to see calculations.
If the company P/FCFE is lower then the P/FCFE of benchmark then company is relatively undervalued.
Otherwise, if the company P/FCFE is higher then the P/FCFE of benchmark then company is relatively overvalued.
Price to FCFE Ratio, Historical
Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
---|---|---|---|---|---|---|
No. shares of common stock outstanding1 | 564,347,000 | 605,720,000 | 668,046,000 | 726,898,000 | 776,032,000 | |
Selected Financial Data (US$) | ||||||
Free cash flow to equity (FCFE) (in thousands)2 | 5,552,600) | 4,643,300) | 6,661,600) | 3,768,200) | 2,414,300) | |
FCFE per share3 | 9.84 | 7.67 | 9.97 | 5.18 | 3.11 | |
Share price1, 4 | 78.64 | 69.63 | 68.65 | 86.72 | 77.12 | |
Valuation Ratio | ||||||
P/FCFE5 | 7.99 | 9.08 | 6.88 | 16.73 | 24.79 | |
Benchmarks | ||||||
P/FCFE, Competitors6 | ||||||
Abbott Laboratories | — | — | — | — | — | |
Cigna Group | — | — | — | — | — | |
CVS Health Corp. | — | — | — | — | — | |
Elevance Health Inc. | — | — | — | — | — | |
Humana Inc. | — | — | — | — | — | |
Intuitive Surgical Inc. | — | — | — | — | — | |
Medtronic PLC | — | — | — | — | — | |
UnitedHealth Group Inc. | — | — | — | — | — |
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
1 Data adjusted for splits and stock dividends.
3 2017 Calculation
FCFE per share = FCFE ÷ No. shares of common stock outstanding
= 5,552,600,000 ÷ 564,347,000 = 9.84
4 Closing price as at the filing date of Express Scripts Holding Co. Annual Report.
5 2017 Calculation
P/FCFE = Share price ÷ FCFE per share
= 78.64 ÷ 9.84 = 7.99
6 Click competitor name to see calculations.
Valuation ratio | Description | The company |
---|---|---|
P/FCFE | Price to free cash flow to equity is cash valuation indicator of stockholders’ equity. | Express Scripts Holding Co. P/FCFE ratio increased from 2015 to 2016 but then slightly decreased from 2016 to 2017. |